483
BASF CorporationBASF Corporation – FDA 483, Nov 17, 2017
Record Details
An FDA inspection of BASF Corporation, an OTC drug manufacturer in East Setauket, NY, revealed significant deficiencies in quality control, process validation, laboratory controls, and equipment qualification. The firm failed to thoroughly investigate out-of-specification results, lacked cleaning and process validations, did not support media expiry dates, and had unqualified manufacturing equipment. These issues indicate a lack of robust quality systems for drug product manufacturing.
View Company Profile
ID · bc2c0d1e-80b8-4f1c-b18d-7fce15c869a0
Other documents for BASF Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.